Wed, 11 Feb 2026

Wed, 11 Feb 2026 Novo Nordisk CEO sees 15 million patient opportunity in Medicare coverage for obesity drugs

Doustdar said Medicare coverage and the launch of Novo's new obesity pill should help gradually boost prescription volumes and offset lower prices in the U.S.

  >>